In recent years, we’ve made significant advances on the technology and algorithm development front, while old incentive structures and legacy organizational behaviors continue to represent the most critical barriers to unlocking the full potential of AI in biomedical research and healthcare delivery....
One of the key lessons learned from the pandemic has been to recognize and focus on advancing impactful science that can quickly be translated into clinical use....
The extent of genomic information utilization in medical practice is strongly linked to the advances in genomic technologies and sciences....
Precision medicine promises a revolutionary understanding of cancers based on genetic alterations instead of primary tumor location and appearance....
Nearly 20 years after the Human Genome Project sequenced 92% of the human genome, scientists just published the first truly complete genome....
Recent advancements of gene and cell therapy offer a glimpse of what’s to come....
One of the most exciting developments in the life sciences and diagnostics is the advancement of liquid biopsy, which is why we are dedicating a Track to it, June 29th, at PMWC 2022 Silicon Valley (June 28-30)....
Pharmacogenomic (PGx) relies on scientific breakthroughs in our understanding of how a person’s unique molecular and genetic profile influences susceptibility to and progression of certain diseases and predicts which medical treatments will likely be safe and effective, and which ones will not....
Real-world data (RWD) and real-world evidence (RWE) have been receiving increasing amounts of attention from both medical researchers and regulators, playing an increasing role in health care decision-making....
The PMWC 2022 AI and Data Sciences Track on January 26-28 at the Santa Clara Convention Center is an outstanding opportunity for all who work with large data sets to learn first-hand from leaders in the field about recent data and technology developments and how the...
